Study of Long-Term Efficacy and Safety of LIB003 in CVD or High Risk for CVD Patients Needing Further LDL-C Reduction
Clinical trial NCT04806893 · UNKNOWN
Trial details
- NCT number
- NCT04806893
- Sponsor
- LIB Therapeutics LLC
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-22
- Primary completion
- 2023-11-15
- Enrollment
- 900
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.